2021
DOI: 10.1021/acs.chemrestox.1c00060
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic Activation and Cytotoxicity of Labetalol Hydrochloride Mediated by Sulfotransferases

Abstract: Labetalol hydrochloride (LHCl), an α- and β-adrenoreceptor blocker, is widely used for the treatment of hypertension as well as angina pectoris. Previous reports have demonstrated the adverse events during clinical application of LHCl, such as liver injury and acute renal failure. The present study aimed to investigate metabolic activation of LHCl to initiate the elucidation of the mechanisms of its liver toxicity. One glutathione (GSH) conjugate was detected in rat and human primary hepatocytes as well as bil… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 28 publications
1
8
0
Order By: Relevance
“…68,69 Labetalol forms GSH conjugates after sulfation via phase II enzymes. 70 Fluconazole is reported to exhibit mitochondrial dysfunction 71 and induce reactive oxygen species (ROS) formation. 72 Iproniazid is reported to form an isopropyl radical capable of covalent binding to protein.…”
Section: ■ Discussionmentioning
confidence: 99%
“…68,69 Labetalol forms GSH conjugates after sulfation via phase II enzymes. 70 Fluconazole is reported to exhibit mitochondrial dysfunction 71 and induce reactive oxygen species (ROS) formation. 72 Iproniazid is reported to form an isopropyl radical capable of covalent binding to protein.…”
Section: ■ Discussionmentioning
confidence: 99%
“…2,6-dichloro-4-nitrophenol is a broad-spectrum inhibitor of sulfotransferases. In hepatocytes, pretreatment with 2,6-dichloro-4-nitrophenol may reduce the hepatotoxicity associated with the application of labetalol hydrochloride ( Yang L. et al, 2021 ). However, whether 2,6-dichloro-4-nitrophenol can be used to treat SSc-PH and its possible interaction pattern with RPS3 still need to be corroborated by more studies.…”
Section: Discussionmentioning
confidence: 99%
“…One is to the anti­hypertensive α- and β-adrenergic receptor antagonist labetalol ( 159 ) which has been studied in more detail (Scheme ). This drug was shown to be associated with in vitro GSH adduct formation in rat and human hepatocytes and in vivo in rats. For an adrenergic agent, labetalol is used at a rather high dose of 200 mg/day.…”
Section: Drugs That Are Benzylic Alcoholsmentioning
confidence: 99%